Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

Autor: Bruix, Jordi, Takayama, Tadatoshi, Mazzaferro, Vincenzo, Chau, Gar-Yang, Yang, Jiamei, Kudo, Masatoshi, Cai, Jianqiang, Poon, Ronnie T, Han, Kwang-Hyub, Tak, Won Young, Lee, Han Chu, Song, Tianqiang, Roayaie, Sasan, Bolondi, Luigi, Lee, Kwan Sik, Makuuchi, Masatoshi, Souza, Fabricio, Berre, Marie-Aude Le, Meinhardt, Gerold, Llovet, Josep M
Zdroj: In The Lancet Oncology October 2015 16(13):1344-1354
Databáze: ScienceDirect